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Susceptibility to Aspergillus Infections in Rats with Chronic
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of Alveolar Macrophages and Impaired Activation of TLR2
Yuting Wu,1 Hong Xu,2 Li Li,2 Weifeng Yuan,2 Deming Zhang,3 and Wenjie Huang1,2,4
Abstract—Clinical evidence indicates that patients with severe chronic obstructive pulmonary disease
(COPD) are more susceptible to Aspergillus. However, the exact mechanisms underlying this effect are
not known. In this study, we used cigarette smoke exposure to generate COPD rat model. colony-
forming units (CFU) count assessment and phagocytosis were applied to evaluate the defense function of
COPD rats against Aspergillus challenge. ELISA, western blotting, and GST-Rac1 pull-down assays
were conducted to determine the expressions of cytokines and TLR2-associated signaling pathway. Our
data showed that Aspergillus burdens increased, phagocytosis of Aspergillus as well as the expressions
of inflammatory cytokines from alveolar macrophages (AMs) were impaired in COPD rats compared
with normal rats. Though TLR2 signaling-related proteins were induced in response to the stimulation of
Aspergillus or Pam3csk4 (TLR2 agonist), the activation of TLR2-associated signaling pathway was
apparently interfered in rats with COPD, compared to that in normal rats. Taken together, our study
demonstrated that COPD caused the deficiency of AMs function and impaired the activation of TLR2/
PI3K/Rac 1 signaling pathway, leading to invasion of Aspergillus infection, which also provides a future
basis for the infection control in COPD patients.
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INTRODUCTION
Invasive pulmonary aspergillosis (IPA) is caused by
Aspergillus and characterized as a life-threatening pneu-
monia due to lung parenchyma invasion with vasculature
erosion and necrosis. Growing evidence suggests that the
incidence of IPA is correlated with the increase of chronic
obstructive pulmonary disease (COPD) [1–3].
Under normal circumstances, Aspergillus species are
widely distributed in nature and have no invasion to im-
munocompetent individuals owing to host immune defense
system. Of note, respiratory mucosal epithelial cells serve
as an anatomic barrier to parenchymal invasion, promote
mucociliary clearance, and ingest inhaled conidia [4].
Alveolar macrophages (AMs) consist of multiple kinds of
immune cells within the alveolar space and act as a first line
of innate host defense against inhaled conidia [5], which
employ an array of receptors to recognize pathogen-
associated molecular patterns (PAMPs) and to facilitate
phagocytic uptake [6].
Cigarette smoking poses as the major risk factor for
COPD and accounts for approximately 85 % of all cases.
About 15 % of smokers will develop COPD, whereas the
incidence in nonsmokers is 1.6% [7]. Exposure to cigarette
smoking markedly impairs lung immunity, resulting in
mucociliary dysfunction, mucus hypersecretion,
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disturbance of the mucosal integrity [8], and easy coloni-
zation of t potentially pathological microorganisms in lung.
Assay of bronchoalveolar lavage fluid (BALF) showed
that 90–95 % of cells were from AMs with properties of
highly phagocytic, production of multiple inflammatory
mediators. Moreover, their role in removal of potentially
pathogenic microorganisms via phagocytosis is essential in
the maintenance of the normally sterile environment within
the lung. One reason for the increased incidence of bacte-
rial infections in the respiratory tract of COPD patients
might be failure of macrophages to clear pathogens [9–
11]. However, mechanism concerning the effect of ciga-
rette smoking at the interaction between Aspergillus and
AMs remains to be further understood.
In the present study, we investigated the features of
the Aspergillus clearance in rat models of smoke-induced
chronic obstructive pulmonary disease. Furthermore, we
analyzed the impact of cigarette smoke on the phagocytosis
of AMs to Aspergillus conidia, and cytokine expression as




Female Wistar rats weighing 230–250 g were pur-
chased from Guangdong Laboratory Animal Center
(Guangzhou, China). The rats were housed under specific
pathogen-free conditions and maintained on a 12-h light–
dark cycle, with food and water ad libitum. All experi-
ments were approved by Southern Medical University
Animal Investigational Committee and were performed in
accordance with the Guide for the Care and Use of
Laboratory Animals published by the Ministry of Health
of China.
Cigarette Smoke Exposure
Cigarette smoke exposure may be used to create
COPDmodel [12]. Rats were placed in a 110 cm × 86 cm ×
72 cm chamber and exposed to cigarette smoke generated
by cigarette smoking machine (Kangda Enterprises,
Guangzhou, China). Ten cigarettes (Cocopalm,
Guangzhou cigarette factory, tar concentration 12 mg)
were burned in 8 min, and the rats stayed in the chamber
for 45 min each time. Animals were exposed twice/day,
6 day/week, for 12 weeks. Control animals were housed in
an identical chamber, exposed to room air without smoke.
Preparation and Administration of A. fumigatus
Conidia
A strain of A. fumigatus isolated from a patient with
invasive aspergillosis was used in this study. To prepare the
inoculum, A. fumigatus grew on Sabouraud dextrose agar
plates for 2 weeks at 37 °C. Conidia were collected by
washing the plates with sterile phosphate-buffered saline
containing 0.2 % (vol/vol) Tween 80. The conidia were
concentrated by centrifugation and determined using a
hemacytometer. Rats were intratracheally inoculated with
a single administration of 1 × 107 conidia of A. fumigatus
in 0.2 ml of sterile saline [13].
Colony-Forming Units (CFU) Count Assessment
Fungal burdens in the lungs were determined by
CFU counting. Rats were sacrificed at selected time
points (1, 3, 5, 7, and 14 days) after exposure. One
gram of lung tissue was aseptically removed and ho-
mogenized with an overhead RW16 Basic S1 Overhead
Stirrer (IKA Works Inc., Wilmington NC) in 9 ml of
sterile saline with gentamicin (0.025 g/l; Sigma) and
chloramphenicol (0.4 g/l; Sigma). Primary homogenate
dilutions were quantitatively cultured by serial dilution,
plated on PDA plates, and incubated at 37 °C for 24 to
36 h, after A. fumigatus fungal burdens (numbers of
CFU per gr of lung tissue) were determined [14].
Bronchoalveolar Lavage (BAL) and AMs Culture
Lungs were lavaged through an intratracheal cannula
with calcium- and magnesium-free PBS supplemented
with 0.6 mM EDTA. A total of 20 ml was used in each
rat in 0.5-ml increments with a dwell-time of 30 s. The cells
from the lavage fluids were collected by centrifugation
300×g for 10 min at room temperature. Isolated cells were
washed with PBS, counted using a hemacytometer, and
cultivated on glass cover slips in RPMI1640 medium sup-
plemented with 10 % heat-inactivated fetal calf serum, 2-
mM glutamine, and penicillin-streptomycin. The cells
were transferred into six well plates followed by the 2-h
incubation with 5 % CO2 at 37 °C. Histological staining
and immunofluorescence analysis using CD68 revealed
that the vast majority of the adherent cells derived from
the alveolar lavages were macrophages.
Phagocytosis
The biotin-calcofluor staining was performed as pre-
viously described [15]. Briefly, swollen conidia were bio-
tinylated using 10 mg/ml sulfo-NHS-LC-biotin (Sigma) in
1311COPD damages innate defense against Aspergillus
50 mM NaHCO3, pH 8.5 for 2 h at 4 °C. Remaining
reactive biotin molecules were inactivated by incubation
in 100-mM Tris–HCl, pH 8.0 for 40 min at 4 °C. For
phagocytosis experiments, macrophages were seeded on
glass cover slips in six well plates at a density of 1 × 106
cells per well. Four hours later, the supernatant was
collected and stored at −70 °C for further use. Then, 1-ml
warm RPMI 1640 was supplemented, and 5 × 106
biotinylated conidia were seeded at each well. After 1 h
at 37 °C and 5 % CO2, the supernatant was removed and
stored at −70 °C after centrifugation. The glass cover slips
were fixed in 3.7 % formaldehyde in PBS for 10 min.
Extracellular conidia were detected using Cy3-labeled
streptavidin (Sigma) (diluted 1: 100 in PBS, 30 min at
37 °C). Extra and intracellular conidia were stained using
0.4 mg/ml calcofluor white (Sigma) in PBS for 30 min.
Macrophages were visualized using 0.1 mg/ml FITC-
labeled concanavalin A (Sigma) in PBS for 30 min at room
temperature (RT). Micrographs taken with Olympus DP72
RBEmicroscope (LeicaMicrosystems, Wetzlar, Germany)
and digitally recorded using the MetaMorph software
(Visitron Systems, Puchheim, Germany) were used for
quantitative analysis. Efficiency of phagocytosis was cal-
culated as phagocytic index and phagocytic rate.
ELISA
Cytokine levels (TNFα, MIP-2, IL-1β, IL-10) in the
supernatants were determined with the commercially avail-
able ELISA kit (R&D Systems Inc. Chicago, IL, USA)
according to the manufacturer’s instructions.
Western Blot
The alveolar lavage was performed in randomly se-
lected COPD group and normal control group (each group
consisted of three rats), respectively. After treating cells as
described above (centrifugation and resuspension), the
cells were transferred into two 25-cm2 culture flasks
followed by the 2-h incubation with 5 % CO2 at 37 °C.
After washing with PBS for three times, we stimulated the
AMs in the COPD group and normal control group for 2 h
by using A. fumigatus conidia or TLR2 agonist Pam3csk4
(Tocris Bioscience). Total proteins samples were extracted
from AMs using lyses buffer containing phenylmethyl
sulfonyfluoride (PMSF) supplemented with protease in-
hibitor cocktail (Roche) and phosphatase inhibitor
PhosSTOP (Roche). The samples were mixed with loading
buffer and denatured, separated by electrophoresis in a
10 % SDS-PAGE gel, and then transferred to PVDF mem-
branes. The membranes were blocked with 5 % skim milk
for 1 h, incubated with anti-TLR2, anti-Rac1 antibody (all
from Abcam, Cambridge, UK), anti-AKT, anti-p-AKT,
anti-GAPDH antibody (all from CST, USA) at 4 °C over-
night. Signals were revealed after incubation with anti-
rabbit IgG secondary antibody (CST, USA) coupled to
peroxidase by using ECL.
GST- Rac1 Pull-down Assays
Cells were washed in ice-cold PBS rapidly and lysed
on ice in 50-mM Tris–HCl (pH 7.4), 1 % Triton X-100,
10 % glycerol, 2 mMMgCl2, 100 mM NaCl, and protein
inhibitor mixture. Lysates were centrifuged at 17,000×g at
4 °C for 5 min, and samples were taken from the superna-
tant to estimate total protein concentration. Twenty micro-
gram of GST-Rac1 fusion bound to sepharose beads were
added to cell lysate and incubated at 4 °C for 30min. Beads
were washed in lysis buffer four times, and bound proteins
were eluted in Laemmli sample buffer. Total proteins and
Rac1 affinity-purified proteins were analyzed by Western
blotting using anti-Rac1 antibody (Abcam, Cambridge,
UK).
Statistical Analysis
Data are presented as mean ± SD. Statistical analyses
were performed using the SPSS version 19.0 software. For
parametric data, mean values were compared using a
Student’s t test. Analysis of variance (ANOVA) was used
to compare mean values for the different groups, followed
by Student–Newman–Keuls test for multiple comparisons.
A P value <0.05 was accepted as statistically significant.
RESULTS
Comparison of Pulmonary Fungal Burdens
Quantitative culture analysis showed that the burdens
ofAspergillus in the lungs were gradually reduced in all the
animals challenged with Aspergillus spores. Of note, the
Aspergillus burdens in COPD group were significantly
higher than those in the control group at each time point
except day 7 (Fig. 1), and no invasive infections by
Aspergillus were observed in the liver, spleen, kidney,
and pancreas tissue in each group.
Phagocytosis of A. fumigatus in AMs
The result of immunofluorescence stain showed a
clear distinction between extra and intracellular conidia
(Fig. 2). In addition, we found that cigarette smoke
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exposure impaired the phagocytosis of A. fumigatus in
AMs. The phagocytic rate in COPD group was much lower
than that in normal group (25.8 ± 4.2 % vs. 50.6 ± 14.7 %,
P = 0.048), but no significant change was observed in
phagocytic index (2.5 ± 0.8 vs. 3.1 ± 0.8, P = 0.38).
Cytokine Expression in COPD Rats
Slight increasing expressions of TNF-α, MIP-2 were
found in COPD rats compared to normal ones. Notably,
after conidia challenge, levels of TNF-α, MIP-2, IL-1β,
and IL-10 were significantly upregulated, indicating an
innate defense of host against Aspergillus. However, the
growing levels of cytokines in COPD rats were lower than
those in normal rats, manifesting impaired defense function
in rats with COPD (Fig. 3).
Expression of TLR2 on AMs of COPD Rats
After the challenge of Aspergillus spores, the expres-
sion of TLR2 receptors on AMs was increased in two
groups and reached a peak on day 5. Moreover, we detect-
ed unequal trend of the change in the percentage of TLR2-
positive cells in two groups. Particularly on day 3 after
infection, TLR2 expression in COPD rats did not show as
high level as that in normal rats (Fig. 4). This suggested
that the upregulation of TLR2 expression on AM might be
delayed in COPD rats.
Fig. 1. CFU count assessment in each group. The analysis of variance
with factorial design showed that difference between normal and COPD
groups was significant (P < 0.001). The Aspergillus burdens in COPD g-
roup were significantly higher than those in control at each time point e-
xcept day 7 (P < 0.05).
Fig. 2. BCS staining of AMs infected with biotinylated. A fumigatus conidia. Differential staining of extra and intracellular conidia. a Extracellular conidia
stained in red using Cy3-labeled streptavidin; b calcofluor white staining (blue) of extra and intracellular conidia; cmacrophages visualized by Concanavalin
A-FITC are shown in green (Concanavalin A-FITC also recognizes the surface of extracellular conidia.) d an overlay of all micrographs. Positions of
extracellular conidia are indicated by arrows.
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Aspergillus fumigates Impairs the Activation
of TLR2/Akt/Rac1 Pathway
To test the TLR2 signaling pathway in rat alveolar
macrophages, we treated rat alveolar macrophages of
COPD model and control rats with the treatment of
Aspergillus or Pam3csk4 for 2 h and evaluated expressions
of TLR2 signaling-related proteins. TLR2 protein expres-
sion in untreated alveolar macrophage from COPD rats
was lower than that from control (Fig. 5a). In the assay of
Aspergillus or Pam3csk4 treatment, there were no signifi-
cant difference in the levels of AKT and total-Rac1 be-
tween the COPD and control groups, but the expression p-
AKT and GTP-Rac1 were upregulated. In addition, the
growing expressions of TLR2, p-AKT, and GTP-Rac1 in
COPD rat group were still lower than those in normal ones
under the stimulation of Aspergillus or TLR2 agonist. As
the phosphorylation of Akt is the downsteam target of
PI3K, while the elevation level of GTP-bound form of
Fig. 3. Cytokine levels in supernatant before and after conidia stimulation. The analysis of variance with factorial design showed differences between control
and COPD groups. There was interaction between grouping and conidia stimulation, suggesting that the alteration trend of TNF-α, MIP-2, IL-1β, and IL-10
in the culture supernatant after stimulation was different between the groups. In control group, cytokine levels increased more significantly. Number sign
signifies the analysis of single factor effect which showed that before conidia stimulation, levels of TNF-α and MIP-2 in COPD group were significantly
higher than those in control group (P < 0.001). Asterisk signifies after spore stimulation, although cytokine concentrations in both groups increased
significantly, the final cytokine levels were significantly higher in control group than in COPD group (P < 0.001).
Fig. 4. Expressions of TLR2 on AMs after intratracheal instillation of
Aspergillus spores in each group. The analysis of variance with factorial
design showed significant difference between normal and COPD groups
(P = 0.049), and there were significant differences between different day
points (P < 0.001). There was interaction between grouping and day poi-
nts, suggesting that the alteration trends of TLR2 receptor cells in two g-
roups were different.
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Rac1 also suggests the activation of Rac1, our data thus
indicated that the activation of TLR2/PI3K signaling path-
way was impaired in COPD rats in response to Aspergillus
in a Rac1-dependent manner (Fig. 5b–d; *P < 0.05, #P <
0.01).
DISCUSSION
Although clinical evidence suggested that the inci-
dence of invasive pulmonary aspergillosis (IPA) in the
context of COPD is increasing, the mechanisms underlying
this association are still poorly understood. In this report,
we have demonstrated that CS-exposure substantially at-
tenuated the clearance of Aspergillus. In addition, the de-
fect in phagocytosis of Aspergillus and inflammatory cy-
tokines release in AMswere observed in COPD rats, which
might be associated with impairment of TLR2 activation in
AMs. These results provide new insight into the mecha-
nisms by which CS-exposure compromises pulmonary
host defense against Aspergillus infection.
In this study, however, even with the weaker scav-
enging of Aspergillus, COPD rats did not develop invasive
aspergillosis in the lung or any other organs, which sug-
gested that being different from immunocompromised
host, COPD rats still have relatively normal defense capa-
bility to Aspergillus. But the attenuated clearance of
Aspergillusmay result in easier spore colonization in lower
respiratory tract, which increases the risk of aspergillosis in
the host.
AMs are the sentinel cells of the lung, patrolling the
airways to remove any inhaled particles or pathogens [16].
Failure of this innate response could lead to pulmonary
damage and persistent infection. AMs fromCOPD patients
phagocytose fewer apoptotic epithelial cells comparedwith
nonsmokers and smokers without COPD [17, 18]. The
present study observed a very clear defect in the phagocytic
response of AMs from COPD rats to Aspergillus conidia.
In the BAL fluid from COPD patients, an increase of
proinflammatory cytokines and chemokines including
TNF-α and IL-8 has been reported, and these mediators
may play an important role in establishing and maintaining
the inflammatory condition [19]. Cigarette exposure can
Fig. 5. A. fumigatus stimulates TLR2/Akt activity through a Rac1-dependent mechanism. a Representative image of the western blot results, which showed
that the TLR2 protein expression level was downregulated in the COPD rats comparing to the control afterA. fumigatus infected. These results have also been
gotten from the protein expression levels of p-AKTandGTP-Rac1. There were no significant differences found in the AKTand total-Rac1 protein expression
levels between the COPD and control groups. b–d Statistical analysis of the western blot results (*P < 0.05, #P < 0.01).
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cause LPS-independent TLR4 activation in AMs, leading
to mediator production [20]. Therefore, it is well under-
stood that we observed relatively higher basic levels of
TNF-α and MIP-2 in the supernatant of AMs prior to
conidia challenge in COPD rats. With the challenge of
conidia, elevated levels of proinflammatory cytokines in-
cluding TNF-α, MIP-2, and IL-1β were observed in two
groups, but more significantly in normal rats.
Proinflammatory cytokines secreted by AMs play impor-
tant role in further activation of AMs. Although CS-
exposure resulted in some degree of AMs activation, when
stimulated with conidia, AMs from COPD rats may not be
activated properly, leading to insufficient secretion of in-
flammatory cytokines. The phagocytic dysfunction mainly
displayed as decline of phagocytic rate, which suggested
that part of the AMs cannot be normally activated.
IL-10 is an important anti-inflammatory cytokine and
can inhibit aggressive inflammatory response. COPD pa-
tients combined with IPA usually exhibit severe wheezing.
Although the mechanism is not clear, we speculate that it
may be associated with allergic reactions. Previous studies
had shown that IL-10 played an important role in the
inhibition of Aspergillus induced allergic reactions in
ABPA [21]. In this study, we observed lower secretion of
IL-10 in COPD rats, which may partly relate to the wheez-
ing in COPD patients with IPA.
Toll-like receptors (TLRs) are the most important
pathogen recognition receptors (PRRs) on macrophages
which can activate innate immunity. As a highly conserved
family of receptors, they recognize common protein and
DNA pattern motifs in microbial pathogens and initiate
signaling events related to cytokines production and T cell
and DC maturation [22, 23]. Recent studies have shown
that TLR2 is involved in recognition of A. fumigates [24].
Our data demonstrated reduced expression of TLR2 on
AMs of COPD rats before the challenge of Aspergillus
spores, which might suggest lower proportion of AMs in
immune surveillance system of COPD group. Under nor-
mal circumstances, the PRRs on AMs will be upregulated
with the stimulation of pathogens or some inflammatory
cyctokines. The upregulation in both groups was observed.
The reason of impaired defense function might partly lie in
the regulation of TLR2 on AMs. On d3 after inoculation,
the proportion of TLR2-positive cells increased by 50.4 ±
14.6 % in control group, but the COPD group was only
28.0 ± 4.1 %. Factorial analysis results showed different
trend of upregulation and downregulation of TLR2 in two
groups. The upregulation of TLR2 in control group was
faster than that in the COPD group. On d14, the percent-
ages of TLR2-positive cells in COPD rats were higher than
those in control rats, which may be associated with contin-
ued stimulation of large number of Aspergillus spores in
the alveolar.
After recognition of microbial products, TLRs may
recruit signal moleculars, such as PI3K. Small molecule
enzyme Rac1 is one of Rho GTP enzyme super family
members, which participates in the regulation of phagocy-
tosis through activating actin cytoskeletal rearrangements
[25, 26]. In some cell types, such as CEF cells, Rac1 is a
downstream target of the PI3K/Akt signaling cascade, and
inactivation of PI3K or Akt was sufficient to suppress Rac1
activation induced by integrin-linked kinase [27].
Therefore, we assessed whether Rac1 is also implicated
in the TLR2 signaling pathway by analyzing activation
of Akt. Our results show that during Aspergillus fumi-
gates or Pam3csk4 stimulation, TLR2 protein expres-
sion level was significantly decreased in the COPD rats
comparing to that in control, and the levels of p-AKT
and GTP-Rac1 were also significantly reduced. This is
consistent with the recent report that TLR-2-MyD88-
dependent signaling-mediated phagocytosis was depen-
dent on PI3K and Rac1 activation during Mlisteria
monocytogenes infection by murine macrophages [28].
Similar finding also demonstrated that stimulation of
TLR4 with LPS leads to activation of PI3K and small
GTPases in the cell line RAW264.7. TLR4-induced
activation of Cdc42 and Rac appears to be independent
of MyD88 [29]. Even though, the limitation in our study
still exists, which involves validating the effect of TLR2
activation by agonist in the prevention and treatment of
Aspergillus in individuals with COPD. Additionally, the
impairment of adaptive immune response in COPD rats
and roles of T-lymphocytes should be further
investigated.
In conclusion, we have demonstrated that CS-
exposure impairs pulmonary clearance of A. fumigatus,
which in turn leads to the deficiency of AMs function,
including delayed upregulation of TLR2. Given the impor-
tant role of TLR2 in maintaining the pathogen defense of
macrophage, further studies regarding to the molecular
mechanism of the expression of TLR2 receptor in COPD
rats could lead to more effective treatment regimens of IPA
in COPD patients.
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